Error loading player: No playable sources found

2030

AGA New Microbiome Mechanisms and Therapies: Complement, Cancer, and Customized Probiotics

Date
May 6, 2023
Explore related products in the following collection:

Society: AGA

The gut microbiome is implicated in a wide range of physiological processes, and holds great, but unrealized, potential for disease treatment and prevention. In this session, rising investigators demonstrate novel biotherapeutic applications of gut microbes, and how the intestinal bacterial community interacts with an arm of the innate immune system. The talks span the topics of bioengineered probiotics, anti-tumor activities of gut microbes, and introduce the complement system in the gut as an effector of antimicrobial defense.

Moderators

Speaker Image for Eugene Chang
University of Chicago
Speaker Image for Phillip Tarr
Washington Univ School of Medicine

Related Products

Thumbnail for AGA The Mucosal Immune Response and Nonimmune Cells in IBD
AGA The Mucosal Immune Response and Nonimmune Cells in IBD
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
Thumbnail for AGA FDA Town Hall
AGA FDA Town Hall
This session was jointly developed by AGA and representatives from the Division of Gastroenterology at the FDA Center for Drug Evaluation and Research…